TRPC3 mediates pyrimidine receptor-induced depolarization of cerebral arteries

Department of Pharmacology, University of Vermont, Burlington, Vermont Submitted 23 August 2004 ; accepted in final form 13 December 2004 We tested the hypothesis that TRPC3, a member of the canonical transient receptor potential (TRP) family of channels, mediates agonist-induced depolarization of arterial smooth muscle cells (SMCs). In support of this hypothesis, we observed that suppression of arterial SMC TRPC3 expression with antisense oligodeoxynucleotides significantly decreased the depolarization and constriction of intact cerebral arteries in response to UTP. In contrast, depolarization and contraction of SMCs induced by increased intravascular pressure, i.e., myogenic responses, were not altered by TRPC3 suppression. Interestingly, UTP-evoked responses were not affected by suppression of a related TRP channel, TRPC6, which was previously found to be involved in myogenic depolarization and vasoconstriction. In patch-clamp experiments, UTP activated a whole cell current that was greatly reduced or absent in TRPC3 antisense-treated SMCs. These results indicate that TRPC3 mediates UTP-induced depolarization of arterial SMCs and that TRPC3 and TRPC6 may be differentially regulated by receptor activation and mechanical stimulation, respectively. transient receptor potential; nonselective cation channels; vascular smooth muscle; uridine triphosphate; vasoconstriction; antisense oligodeoxynucleotides Address for reprint requests and other correspondence: S. A. Reading, Dept. of Pharmacology, Given Bldg. Rm. B316, Univ. of Vermont, Burlington, VT 05405 (E-mail: sreading{at}uvm.edu )